Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nebih Lolak"'
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 38, Iss 1 (2023)
A novel series of twelve aromatic bis-ureido-substituted benzenesulfonamides was synthesised by conjugation of aromatic aminobenzenesulfonamides with aromatic bis-isocyanates. The obtained bis-ureido-substituted derivatives were tested against four s
Externí odkaz:
https://doaj.org/article/27d3d6164b084861b578bf702b6f3f3b
Autor:
Mehmet Oguz, Erbay Kalay, Suleyman Akocak, Alessio Nocentini, Nebih Lolak, Mehmet Boga, Mustafa Yilmaz, Claudiu T. Supuran
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 1215-1223 (2020)
A series of novel calix[4]azacrown substituted sulphonamide Schiff bases was synthesised by the reaction of calix[4]azacrown aldehydes with different substituted primary and secondary sulphonamides. The obtained novel compounds were investigated as i
Externí odkaz:
https://doaj.org/article/0f89ebb89dde45aea88d26dfdb740011
Publikováno v:
Journal of the Turkish Chemical Society Section A: Chemistry. :435-442
Herein, a series of twelve bis-hydrazone substituted isovanilline derivatives 3(a-l), were freshly re-synthesized by the reaction of bis-aldehydes with substituted hydrazide derivatives since these compounds previously showed potent aldose reductase
Autor:
Hasan Aydin, Süleyman Akocak, Nebih Lolak, Önder Yumrutaş, Uğur Uslu, Ibrahim Bozgeyik, Fatih Üçkardeş, Selami Günal, Onur Ceylan
Publikováno v:
Journal of Biochemical and Molecular Toxicology.
Autor:
Suleyman Akocak, Nebih Lolak, Hatice Esra Duran, Mesut Işık, Cüneyt Türkeş, Mustafa Durgun, Şükrü Beydemir
Sulfonamide compounds known as human carbonic anhydrase (hCA) inhibitors are used in the treatment of many diseases such as epilepsy, antibacterial glaucoma, various diseases. 1,3-diaryl-substituted triazenes and sulfaguanidine are used for therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eebe77f75bad7fe5d08c1b026d857a0
https://doi.org/10.21203/rs.3.rs-2812331/v1
https://doi.org/10.21203/rs.3.rs-2812331/v1
Publikováno v:
Pharmaceutical Chemistry Journal. 56:345-349
Autor:
Nebih Lolak, Mehmet Boga, Gorkem Deniz Sonmez, Muhammed Tuneg, Aslinur Dogan, Suleyman Akocak
Publikováno v:
Pharmaceutical Chemistry Journal. 55:1338-1344
In this work, a series of seven bis-histamine Schiff bases (H1-H4) and bis-spinaceamine substituted derivatives (SPH1, SPH2, and SPH4) were successfully re-synthesized to evaluate their antioxidant properties by several bioanalytical methods such as
Autor:
Nebih Lolak, Süleyman Akocak, Mustafa Durgun, Hatice Esra Duran, Adem Necip, Cüneyt Türkeş, Mesut Işık, Şükrü Beydemir
Publikováno v:
Molecular Diversity.
To discover alternative substances to compounds used to treat many diseases, especially treating Alzheimer's disease (AD) and Parkinson's disease targeting carbonic anhydrase (hCA) and acetylcholinesterase (AChE) enzymes, is important. For this purpo
Publikováno v:
Bioorganic and Medicinal Chemistry Reports. 3:22-31
A series of twenty 1,3,5-triazine-substituted ureido benzenesulfonamides 2 (a-e) and 3 (a-o) were re-synthesized and assayed for antioxidant properties by using several different methods including 1,1-diphenyl-2-picryl hydrazyl (DPPH) free radical sc
Autor:
Erbay Kalay, Nebih Lolak, Suleyman Akocak, Mehmet Boga, Alessio Nocentini, Mustafa Yilmaz, Mehmet Oguz, Claudiu T. Supuran
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 1215-1223 (2020)
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
A series of novel calix[4]azacrown substituted sulphonamide Schiff bases was synthesised by the reaction of calix[4]azacrown aldehydes with different substituted primary and secondary sulphonamides. The obtained novel compounds were investigated as i